Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
Ways to Give
About Us

Read Our Newsletter

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Your New Normal

Social Media

Newsroom

For press inquiries about the Gastric Cancer Foundation, please contact: Mediainfo@gastriccancer.org

Gastric Cancer Foundation

Tax ID 27-2978173

info@gastriccancer.org

PO Box 338
Millbrae, CA 94030

For Deliveries:
Gastric Cancer Foundation
501 Broadway, #338
Millbrae, CA 94030-1907

Site Map

Gastric Cancer
Accelerate Research
Patient Resources
Nutrition
- Eating and Healing
- Gesundheit Kitchen
  - Watch Episodes
  - Printable Recipes
Ways to Give
About Us

Social Feed

Gastric Cancer Foundation

10 hours ago

In patients with HER2-positive gastric cancer that had progressed after initial treatment, the targeted antibody drug conjugate Enhertu produced a significant improvement in survival over ramucirumab and paclitaxel in phase 3 trial. ... See MoreSee Less

ENHERTU® Demonstrated Statistically Significant and Clinically Meaningful Improvement in Overall Survival in Patients with HER2 Positive Metastatic Gastric Cancer at Interim Analysis of DESTINY-Gastric04 Phase 3 Trial

www.biospace.com

TOKYO & BASKING RIDGE, N.J.--(BUSINESS WIRE)--Positive topline results from the DESTINY-Gastric04 phase 3 trial showed ENHERTU® (trastuzumab deruxtecan) demonstrated a statistically significant and c...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 day ago

Gastric Cancer is a proud founding member of Test Your Biomarkers — a national campaign with the goal of spreading awareness about the importance of biomarker testing in the treatment of stomach cancer. We are delighted to offer patients another resource to learn more about treatment options. Learn more at testyourbiomarkers.org/. ... See MoreSee Less

Home

testyourbiomarkers.org

Biomarkers are the key to treating stomach cancer. Test first. Because the best treatment for your stomach cancer can be individualized.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

3 days ago

The immunotherapy drug Imfinzi showed “meaningful improvement” in survival in early-stage gastric cancer when given in combination with chemotherapy and surgery, AstraZeneca reported.www.astrazeneca.com/media-centre/press-releases/2025/imfinzi-improved-efs-in-early-stage-gastric-... ... See MoreSee Less

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

The role of the bacteria H. pylori in gastric cancer is well known, but researchers in England discovered that other bacteria leak through the stomach lining in the precancerous condition of gastric intestinal metaplasia, opening a potential new path to prevention, they said. ... See MoreSee Less

Study reveals new insights into the role of gastric bacteria in stomach cancer development

www.news-medical.net

A pioneering study has revealed new insights into the role of gastric bacteria in stomach cancer development that could pave the way for a more effective treatment of pre-cancer according to a study p...

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Gastric Cancer Foundation

1 week ago

Gastric Cancer Foundation grant recipient Timothy Wang led a study that found that electrical signaling between cancer cells and sensory nerves fuels the growth of gastric cancer, indicating that drugs used to treat brain disorders might also prove effective in fighting cancer. ... See MoreSee Less

Stomach Cancer Uses Nerve Connections to Fuel Growth, New Study Finds

www.insideprecisionmedicine.com

Repurposing existing drugs, such as those designed for neurological conditions, could provide a new path to target cancer more effectively.

View on Facebook

· Share

Share on Facebook Share on Twitter Share on Linked In Share by Email

Subscribe to Our Newsletter

We’ll deliver our monthly newsletter to your Inbox with Foundation updates, news about cutting edge research and trends in the field, and how to make a difference.

Fields marked with an * are required

Name

Email *

If you are a human seeing this field, please leave it empty.

EVENTS | NEWS | CONTACT | DONATE

Social Media

Newsroom

Categories

Tags